Supplementary Table 1 from Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)

Authors :: Amit M. Oza
John J. Wright
Ming-Sound Tsao
Olga Ludkovski
Suzanne Kamel-Reid
Qian Tan
Judy Quintos
Anjali Mehta
Stephanie Lheureux
Prafull Ghatage
Katia Tonkin
Mihaela Cristea
Carolyn Johnston
Waldo Jimenez
Daniela Matei
Koji Matsuo
Jean Hurteau
Gini F. Fleming
Stephen Welch
Marcus O. Butler
Angela Jain
Julia V. Burnier
Lisa Wang
Hal W. Hirte
Neesha C. Dhani
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplemental Table S1. 48 genes included in the TruSeq Amplicon Cancer Panel (TSACP, Illumina). Panel includes 212 amplicons covering a total genomic region 35.84 kb.

Full Text Access

Tools